Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results

AIM: To evaluate the role of a therapeutic regimen with plasma exchange, intravenous immunoglobulins and rituximab in chronic-active antibody-mediated rejection (cAMR) settings. METHODS: We compared 21 kidney transplant recipients (KTRs) with a diagnosis of cAMR in a retrospective case-control analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Mella, Alberto, Gallo, Ester, Messina, Maria, Caorsi, Cristiana, Amoroso, Antonio, Gontero, Paolo, Verri, Aldo, Maletta, Francesca, Barreca, Antonella, Fop, Fabrizio, Biancone, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134268/
https://www.ncbi.nlm.nih.gov/pubmed/30211026
http://dx.doi.org/10.5500/wjt.v8.i5.178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134268/
https://www.ncbi.nlm.nih.gov/pubmed/30211026
http://dx.doi.org/10.5500/wjt.v8.i5.178

Ejemplares similares